Telomere length of blood-derived mononuclear cells from cancer patients during G-CSF-enhanced marrow recovery

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 1, 1996, Pages

  Kronenwett, Ralf ^a   Murea, Simona ^b   Haas, Rainer ^a,b,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Department of Internal Medicine V ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADJUVANT CHEMOTHERAPY; ADULT; CANCER; CANCER PATIENT; CONFERENCE PAPER; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TELOMERE;

ADULT; ANTIGENS, CD34; BASE SEQUENCE; DNA, NEOPLASM; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERE;

EID: 0029861315     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Blackburn EH. Structure and function of telomeres. Nature (London) 1991; 350: 569-573.
2. Sandell LL, Zakian VA, Loss of a yeast telomere: Arrest, recovery, and chromosome loss. Cell 1993; 75: 729-739.
3. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 265: 271-282.
4. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405-413.
5. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-529.
6. Counter CM, Avilion AA, LeFeuvre CE et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11: 1921-1929.
7. Kim NW, Piatyszek MA, Prowse K et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
8. Counter CM, Gupta J, Harley CB et al. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-2320.
9. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995 92: 9082-9086.
10. Harley CB, Vaziri H, Counter CM, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992; 27: 375-382.
11. Vaziri H, Schächter F, Uchida I et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993; 52: 661-667.
12. Vaziri H, Dragowska W, Allsopp RC et al. Evidence for a mitotic clock in human hematopoietic stem cells Loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-9860.
13. Lindsey J, McGill NI, Lindsey LA et al. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991; 256: 45-48.
14. Hastie ND, Dempster M, Dunlop MG et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346: 866-868.
15. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-460.
16. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
17. Lansdorp PM. Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci 1995; 108: 1-6.
18. Haas, R, Moos M, Karcher A et al. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 1685-1692.
19. Nicol A, Nieda M, Donaldson C et al. Analysis of cord blood CD34+ cells purified after cryopreservation. Exp Hematol 1995; 23: 1589-1594.
20. Lane TA, Law P, Maruyama M et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 1995; 85: 275-282.
21. Pantel K, Felber E, Schlimok G. Detection and characterization of residual disease in breast cancer. J Hematother 1994; 3: 315-322.
22. Haas R, Möhle R, Pförsich M et al. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells. Blood 1995; 85: 1936-1943.
23. Ausubel FM. Current protocols in molecular biology. New York, Chichester, Brisbane, Toronto, Singapore, 1987, John Wiley & Sons.
24. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: Relation to aging. Proc Natl Acad Sci USA 1995; 92: 258-262.
25. Haas R, Möhle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
26. Ohyashiki K, Ohyashiki JH, Fujimura T et al. Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability. Cancer Genet Cytogenet 1994; 78: 64-67.
27. Hiyama K, Hirai Y, Kyoizumi S et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715.